Study of GS-1427 in Participants With Moderately to Severely Active Ulcerative Colitis

Conditions: Ulcerative Colitis Interventions: Drug: GS-1427; Drug: Ustekinumab; Drug: Placebo-to-match GS-1427 Sponsors: Gilead Sciences Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials